Steven Woloshin

Dartmouth College — United States

Economics, Econometrics and Finance · Social Sciences

63h-index15.9kcitations264works4.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Health Systems, Economic Evaluations, Quality of Life(46), Pharmaceutical industry and healthcare(36), Global Cancer Incidence and Screening(34), Pharmaceutical Economics and Policy(21), Healthcare cost, quality, practices(20)

Publications257 total

Overall survival benefits of cancer drugs initially approved by the US Food and Drug Administration on the basis of immature survival data: a retrospective analysis
The Lancet Oncology·2024· 35 citedOpen Access
Bad news: how the media reported on an observational study about cardiovascular outcomes of COVID-19
BMJ evidence-based medicine·2024
Physicians’ Perspectives On FDA Regulation Of Drugs And Medical Devices: A National Survey
Health Affairs·2024· 20 cited
The New USPSTF Mammography Recommendations — A Dissenting View
New England Journal of Medicine·2023· 36 cited
55 Trends in use of the new MeSH term ‘overdiagnosis’ – a scoping review
2023· 1 citedOpen Access
Overdiagnosis and too much medicine in a world of crises
BMJ·2023· 23 citedOpen Access
Updating the Know Your Chances Website to Include Smoking Status as a Risk Factor for Mortality Estimates
JAMA Network Open·2023· 6 citedOpen Access
Physician Perspectives on the Food and Drug Administration's Decision to Grant Accelerated Approval to Aducanumab for Alzheimer's Disease
Clinical Pharmacology & Therapeutics·2023· 6 citedOpen Access
Communicating health information with visual displays
Nature Medicine·2023· 29 citedOpen Access
Direct-to-Consumer Low-Testosterone Clinics—Where Is the Federation of State Medical Boards?
JAMA Internal Medicine·2023· 4 cited
Association between tobacco product use and asthma among US adults from the Population Assessment of Tobacco and Health (PATH) Study waves 2–4
BMJ Open Respiratory Research·2023· 15 citedOpen Access
Therapeutic Value of Drugs Frequently Marketed Using Direct-to-Consumer Television Advertising, 2015 to 2021
JAMA Network Open·2023· 10 citedOpen Access
Communicating uncertainty about the effects of wearing glasses to reduce the chance of getting COVID: protocol for a randomized trial
Zenodo (CERN European Organization for Nuclear Research)·2022Open Access
Communicating uncertainty about the effects of wearing glasses to reduce the chance of getting COVID: protocol for a randomized trial
Zenodo (CERN European Organization for Nuclear Research)·2022Open Access
Cancer overdiagnosis: A challenge in the era of screening
Journal of the National Cancer Center·2022· 41 citedOpen Access
What to Know About the Alzheimer Drug Aducanumab (Aduhelm)
JAMA Internal Medicine·2022· 38 citedOpen Access
Tobacco Use and Respiratory Symptoms Among Adults: Findings From the Longitudinal Population Assessment of Tobacco and Health (PATH) Study 2014–2016
Nicotine & Tobacco Research·2022· 39 citedOpen Access
Tobacco Product Use and Functionally Important Respiratory Symptoms Among US Adolescents/Young Adults
Academic Pediatrics·2022· 16 citedOpen Access
Assessing How Consumers Interpret and Act on Results From At-Home COVID-19 Self-test Kits
JAMA Internal Medicine·2022· 34 citedOpen Access
Difficulty Obtaining Behavioral Health Services for Children: A National Survey of Multiphysician Practices
The Annals of Family Medicine·2022· 22 citedOpen Access
← Previouspage 2 of 13Next →

Frequent Co-authors

Lisa M. Schwartz(42), H. Gilbert Welch(16), Renda Soylemez Wiener(6), Wolfgang Gaissmaier(3), Angela B. Mariotto(3), Gerd Gigerenzer(2), Lisa Schwartz(2), John Brodersen(2), Nadia Howlader(2), H. Cho(2), L. M. Schwartz(2), Anna N.A. Tosteson(2), Stephanie Byram(2), Baruch Fischhoff(2), Michael K. Gould(2), Robin J. Larson(2), Elke Kurz‐Milcke(1), Neeraj G. Patel(1), Aaron S. Kesselheim(1), Lyndal Trevena(1)